Phase I drug-drug interaction trial of simeprevir in combination with VX 135 in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 30 Jul 2013
Price : $35 *
At a glance
- Drugs Simeprevir (Primary) ; VX 135 (Primary)
- Indications Hepatitis C
- Focus Pharmacokinetics
- 30 Jul 2013 Status changed from recruiting to completed, as reported by a Vertex media release.
- 30 Apr 2013 Status changed from planning to recruiting, based on information in a Vertex Pharmaceuticals media release stating that this study is ongoing.
- 19 Nov 2012 New trial record